The effect on memory of chronic prednisone treatment in patients with systemic disease

Neurology

Volumn 47, Issue 6, 1996, Pages 1396-1402

  Keenan, P A ^a,b   Jacobson, M W ^a   Soleymani, R M ^a   Mayes, M D ^a   Stress, M E ^a   Yaldoo, D T ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE;

ADULT; AGED; AMNESIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; STEROID THERAPY; TASK PERFORMANCE; WORD RECOGNITION;

EID: 0029776614     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.6.1396     Document Type: Article

References (65)

1. Sloviter RS, Valiquette G, Abrams GM, et al. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 1989;243:535-538.
2. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985;5:1222-1227.
3. Sapolsky RM. Stress, the aging brain, and the mechanisms of neuron death. Cambridge: The MIT Press, 1992.
4. Squire LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992; 99:195-231.
5. Milner B. Memory and the medial temporal regions of the brain. In: Prebram KH, Broadbent DE, eds. Biology of memory. New York: Academic Press, 1970;29-50.
6. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 1986;6:2950-2967.
7. Zola-Morgan S, Squire LR, Rempel N, et al. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci 1992;12:2582-2596.
8. Eichenbaum H, Otto T, Cohen, NJ. The hippocampus - What does it do? Behav Neural Biol 1992;57:2-36.
9. Roediger HL. Implicit memory: retention without remembering. Am Psychol 1990;9:1043-1056.
10. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985;229:1397-1400.
11. Sapolsky RM, McEwen BS. Stress, glucocorticoids, and their role in degenerative changes in the aging hippocampus. In: Crook T, Bartus RT, Ferris S, Gershon S, eds. Treatment development strategies for Alzheimer's disease. Madison: Mark Powley Associates, 1986:151-171.
12. Sapolsky RM, Krey LC, McEwen BS. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology 1984;114:287-292.
13. Luine V, Villegas M, Martinez C, et al. Repeated stress causes reversible impairments of spatial memory performance. Brain Res 1994;639:167-170.
14. Luine V, Villegas M, Martinez C, et al. Stress-dependent impairments of spatial memory: role of 5-HT. Brain corticosteroid receptors: studies on the mechanism, function, and neurotoxicity of corticosteroid action. Ann NY Acad Sci 1994;746: 403-404.
15. Sapolsky RM, Armanini MP, Packan DR, et al. Glucocorticoid feedback inhibition of adrenocorticotropic hormone-secretagogue release: relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 1990; 57:328-336.
16. Horner HC, Packan DR, Sapolsky RM. Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990;52:57-64.
17. Watanabe YE, Gould E, Cameron D, et al. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 1992;2:431-436.
18. Diamond DM, Bennet MC, Fleshner M, et al. Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 1992;2:421-430.
19. Pavlides C, Watanabe Y, McEwen BS. Effects of glucocorticoids on hippocampal long-term potentiation. Hippocampus 1993;3:183-192.
20. Varney NR, Alexander B, Macindoe JH. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 1984;141:369-372.
21. Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's syndrome: relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med 1981;141:215-219.
22. Starkman MN, Gebarski SS, Berent S, et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32: 756-765.
23. Wolkowitz OM, Reus VI, Weingartner H, et al. Cognitive effects of corticosteroids. Am J Psychiatry 1990;147:1297-1303.
24. Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairment in explicit memory performance in adult humans. J Neurosci 1994;14:2047-2053.
25. Newcomer JW, Craft S, Selke G. Glucocorticoid-induced memory deficits in adult humans: a replication with preliminary evidence for a biphasic dose-response curve [abstract]. American College of Neuropsychopharmacology, Abstracts of Panels and Posters 1994:189.
26. Sharma S, Turken A, Schwartz G, et al. A longitudinal study of dehydroepiandrosterone sulfate (DHEA-S) levels, cortisol levels and cognitive function in elderly human subjects [abstract]. Society for Neuroscience Abstracts 1995;21:1709.
27. Lupien S, Ngo T, Rainville C, et al. Spatial memory as measured by a human maze in aged subjects showing various patterns of cortisol secretion and memory function [abstract]. Society for Neuroscience Abstracts 1995;21:1709.
28. Meaney MJ, Gaudreau S, Sharma S, et al. Cortisol response and memory function following a psychological stress in healthy elderlies: relationship with past cortisol history [abstract]. Society for Neuroscience Abstracts 1995;21:1687.
29. Frith CD. Schizophrenia, memory and anticholinergic drugs. J Abnorm Psychol 1984;93:339-341.
30. Spohn HE, Strauss ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol 1989;98:367-380.
31. Carroll BJ, Feinberg M, Greden JF, et al. Specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 1981;38:15-22.
32. Uhde TW, Boulenger JP, Jimerson DC, et al. Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmacol Bull 1984;20:426-430.
33. Privitera MR, Greden JF, Gardner RW, et al. Interference by carbamazepine with the dexamethasone suppression test. Biol Psychiatry 1982;17:611-620.
34. Swartz CM, Dunner FJ. Dexamethasone suppression testing of alcoholics. Arch Gen Psychiatry 1982;39:1309-1312.
35. Spitzer RL, Williams JB, Gibbon M, et al. Structured clinical interview for DSM III-R. New York: State Psychiatric Institute, 1989.
36. Benton AL, Hampshire K, des Varney NR, et al. Contributions to neuropsychological assessment. New York: Oxford University Press, 1983.
37. Benton AL, Hamsher K des. Multilingual aphasia examination. Iowa City: University of Iowa, 1978.
38. Rao SM, Hammeke TA, McQuillen MP, et al. Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 1984;41:625-631.
39. Raven JC. Colored progressive matrices sets a, ab, b. London: H.K. Lewis, 1947.
40. Wechsler D. Wechsler Memory Scale-Revised. San Antonio: The Psychological Corporation, 1987.
41. Delis D, Kramer J, Kaplan E, et al. California Verbal Learning Test. San Antonio: Harcourt Brace Jovanovich, 1987.
42. Squire LR, Shimamura AP, Graft P. Strength and duration of priming effects in normal subjects and amnesic patients. Neuropsychologia 1987;25:195-210.
43. Weintraub S, Mesulam MM. Principles of behavioral neurology. In: Mesulam M, ed. Philadelphia: F.A. Davis, 1985;71-115.
44. Blair JR, Spreen O. Predicting premorbid IQ: a revision of the National Adult Reading Test. Clin Neuropsycho 1989;3:129-136.
45. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio: Harcourt Brace Jovanovich, 1987.
46. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;5:56-62.
47. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435.
48. Butters N, Miliotis P. Amnesic disorders. In: Heilman KM, Valenstein E, eds. Clinical neuropsychology. New York: Oxford University Press, 1979.
49. Eldridge JC, Fleenor DG, Kerr DS, et al. Impaired up regulation of type II corticosteroid receptors in hippocampus of aged rats. Brain Res 1989;30:478:248-256.
50. Landfield PW, Eldridge JC. Increased affinity of type II corticosteroid binding in aged rat hippocampus. Exp Neurol 1989; 106:110-113.
51. Reul JM, Tonnaer JA, deKloet ER. Neurotrophic ACTH analogue promotes plasticity of type I corticosteroid receptor in brain of senescent rats. Neurobiol Aging 1988;9:253-260.
52. Landfield PW, Baskin RK, Pitler TA. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science 1981;214:581-584.
53. Branconnier R, Oxenkrug G, McIntyre I, et al. Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach. Psychopharmacology (Berl) 1984;84:274-275.
54. Oxenkrug GF, Pomara N, McIntyre IM, et al. Aging and cortisol resistance to suppression by dexamethasone: a positive correlation. Psychiatry Res 1983;10:125-130.
55. Dilman V, Lapin I, Oxenkrug, G. Serotonin and aging. In: Essman W, ed. Serotonin in health and disease. New York: Spectrum Press, 1979.
56. O'Brien JT, Schweitzer I, Ames D, et al. Cortisol suppression by dexamethasone in the healthy elderly: effects of age, dexamethasone levels, and cognitive function. Biol Psychiatry 1994;36:389-394.
57. Gurevich D, Siegel B, Dumlao M, et al. HPA axis responsitivity to dexamethasone and cognitive impairment in dementia. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:297-308.
58. Ferrier IN, Pascual J, Charlton B, et al. Cortisol, ACTH and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry 1988;23:252-260.
59. Weiner MF, Davis BM, Mohs RC, et al. Influence of age and relative weight on cortisol suppression in normal subjects. Am J Psychiatry 1987;144:646-649.
60. Greden JF, Flegel P, Haskett R, et al. Age effects in serial hypothalamic-pituitary-adrenal monitoring. Psychoneuroendocrinology 1986;11:195-204.
61. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301.
62. Aisen PS, Fagarsan M, Efthimiopoulos S, et al. The development of anti-inflammatory treatment for Alzheimer's disease [abstract]. American College of Neuropsychopharmacology 1995:33.
63. McGeer PL, McGeer E, Rogers J, et al. Anti-inflammatory drugs and Alzheimer's disease. Lancet 1990;335:1037.
64. Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 1994;44:227-232.
65. Basavaraju N, Phillips SL. Cortisol deficient state: a cause of reversible cognitive impairment and delirium in the elderly. J Am Geriatr Soc 1989;37:49-51.